+0.88%
Today
Loading 1D prices…
Company profile
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Sector
Health Care
Industry
Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
Display currency
USD
Location
Carmel, IN, United States
Employees
24
Fiscal year end
1231
CIK
1933567
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HYPRHyperfine Inc. Class A Common Stock | $83.8M | $13.6M | -262.29% | -$0.43 | +0.51% | Buy |
| OMOutset Medical Inc. Common Stock | $60.3M | $119.5M | -68.34% | -$5.37 | -1.83% | Buy |
| ECORelectroCore Inc. Common Stock | $86.7M | $32M | -43.60% | -$1.65 | +4.68% | Buy |
| POCIPrecision Optics Corporation Inc. Common stock | $47.7M | $22.8M | -15.49% | -$0.46 | -0.68% | Unrated |
| VANIVivani Medical Inc. Common Stock (DE) | $114.6M | $0.00 | — | -$0.43 | +1.60% | Buy |